DORC Global

What DORC Global does

DORC Global (legally D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.) is a Netherlands-headquartered developer and manufacturer of ophthalmic surgical equipment, instruments, and surgical liquids, founded in 1983. The company's portfolio centres on the EVA NEXUS surgical platform — an integrated system for vitreoretinal and cataract procedures — and its associated consumables ecosystem, including the TDC VELOCE high-speed vitrectomy cutter, the EVA AVETA trocar cannula system (featuring a patent-pending Push-Fit infusion connection), the EVA INICIO microinjection system, and the SURGICON line of single-use ophthalmic knives. DORC's surgical dye franchise includes VisionBlue, the only FDA-approved trypan blue stain for anterior segment cataract surgery, trusted in over 10 million cataract surgeries since its 2004 launch, and MEMBRANEBLUE-DUAL for ILM and ERM staining during macular surgery (used in over 3 million procedures). The company sells across three primary surgeon segments — vitreoretinal surgeons, cataract surgeons, and corneal surgeons (DMEK) — via a hybrid go-to-market combining direct sales organisations in 15+ countries and an authorised distributor network reaching 100+ countries.

The business model combines capital equipment sales (EVA NEXUS platforms) with high-volume recurring consumable revenue from sterile-packed cutters, trocars, dyes, tamponades, laser probes, diathermy handles, and microinjection needles sold against the installed base. Pricing is quote-based and not publicly disclosed. DORC's commercial footprint includes regional offices in Austria, China, Germany, France, Italy, Spain, Sweden, the UK, and the United States, supporting field sales to hospitals, eye clinics, and individual ophthalmic surgeons. The company employs 800+ professionals globally and is currently a wholly-owned subsidiary of Carl Zeiss Meditec AG following the completion of that acquisition on 4 April 2024, having been announced in December 2023. DORC holds sustainability credentials including an EcoVadis Bronze Medal (2023) and ACE Global Silver Partner status (2024).

Name

DORC Global

Legal name

D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.

Website

https://dorc.eu

Company type

Private

Founded year

1983

Operating status

Operating

Short description

DORC Global is a Netherlands-founded (1983) ophthalmic surgical device manufacturer, now a wholly-owned subsidiary of Carl Zeiss Meditec AG, supplying the EVA NEXUS surgical platform, instruments, consumables, and surgical dyes to vitreoretinal and cataract surgeons across 100+ countries.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)

akta.pro primary industry

Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Cornea & External Disease Surgical Devices (Keratoplasty Tools, Cross-Linking Systems, Amniotic Membrane Delivery) (HLAHAJAK)

Keywords

• Ophthalmic surgical equipment
• Vitreoretinal surgery instruments
• Cataract surgery products
• Ophthalmic surgical consumables
• Intraocular surgical dyes

Headquarters

HQ city

Zuidland

HQ country

Netherlands

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. Surgical Systems and Capital Equipment: DORC generates revenue through the sale of its flagship surgical platforms including the EVA NEXUS surgical system. These capital equipment sales are made through direct sales organisations in key markets and through the global distributor network.
2. Surgical Consumables: Significant recurring revenue from consumable products including vitrectomy cutters, trocars, laser probes, microinjection cannulas, diathermy handles, surgical dyes (VisionBlue, MEMBRANEBLUE-DUAL), surgical tamponades, and surgical instruments. Consumables are sold in sterile packaging (e.g., Box/5, Box/6) and represent recurring revenue from the established surgical instrument install base.
3. Surgical Instruments: Sale of reusable and disposable vitreoretinal and cataract surgical instruments including microforceps, microscissors, backflush instruments, membrane instruments, irrigation/aspiration handpieces, and ophthalmic knives under the SURGICON brand. Instruments are available in multiple gauge sizes (20G, 23G, 25G, 27G) and are sold as both reusable and disposable variants.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

DORC Global develops, manufactures, and distributes ophthalmic surgical systems, instruments, consumables, and surgical liquids for vitreoretinal, cataract, and corneal surgery. Its flagship EVA NEXUS surgical system is paired with a broad portfolio of single-use instruments (trocars, microinjection, knives), surgical dyes (VisionBlue, MEMBRANEBLUE-DUAL), tamponades, and laser probes used by ophthalmic surgeons worldwide.

Product overview

DORC Global offers a comprehensive portfolio of equipment, instruments, and consumables for ophthalmic surgery, organized primarily around two surgical domains: vitreoretinal and cataract procedures. The core platform is EVA NEXUS, a surgical system that supports multiple consumable and instrument lines. Key consumable systems include EVA AVETA (trocar cannula system with Push-Fit infusion connection), EVA INICIO (microinjection system), VisionBlue (FDA-approved trypan blue stain for cataract surgery), and MEMBRANEBLUE-DUAL (surgical dye for macular surgery). The portfolio also includes TDC VELOCE (high-speed vitrectomy cutter), extensive microforceps/microscissors, backflush instruments, diathermy handles, laser probes, and microinjection cannulas. The company exports to approximately 100 countries with direct sales organizations in multiple European countries, USA, China, and India.

Differentiator

Problem solved

Functional benefit

Brands

• EVA NEXUS: Surgical system platform for ophthalmic surgery
• VisionBlue
• EVA INICIO
• EVA AVETA
• TDC VELOCE
• MEMBRANEBLUE-DUAL
• SURGICON

Quantifiable outcome

• VisionBlue used in over 10 million cataract surgeries since 2004 launch
• +5 more outcomes

Named customers4 records

Segments3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Carl Zeiss Meditec AG (ZEISS Medical Technology)coreStrategic or Co-development Partner · 4 April 2024Carl Zeiss Meditec AG completed its acquisition of D.O.R.C. on April 4, 2024. ZEISS Medical Technology and DORC cross-reference each other's products, with DORC products (EVA NEXUS, etc.) designed to complement ZEISS ophthalmic surgical equipment. ZEISS Medical Technology is listed as a partner on DORC's website. The acquisition positions DORC as a key component of ZEISS Medical Technology's ophthalmology portfolio.
• Elena Barraquer FoundationminorOthersDORC supports the Elena Barraquer Foundation, which provides ophthalmic care globally, aligning with DORC's mission to advance ophthalmic surgical healthcare.
• ACE Global (ACECARES Global)minorGTM or Marketing PartnerDORC is a Silver Partner of ACE Global, an organisation working to eliminate avoidable blindness and advance equitable eye care globally. DORC supports ACE Global's mission through this partnership.
• The Eye Care FoundationminorOthersDORC supports The Eye Care Foundation, an organisation dedicated to preventing blindness and providing eye care in developing countries.
• ESASO (European School for Advanced Studies in Ophthalmology)minorGTM or Marketing PartnerDORC supports ESASO, the European School for Advanced Studies in Ophthalmology, contributing to ophthalmic education and training.
• CIRCOminorStrategic or Co-development PartnerCIRCO, supported by the Dutch government, encourages entrepreneurs and professionals to design or revisit products, services, and business models for the circular economy. DORC collaborates with CIRCO as part of its sustainability initiatives.
• ESCH-R (Sustainable Hospital Consortium)minorStrategic or Co-development PartnerESCH-R is a consortium of researchers from various universities, surgeons, and industry professionals studying the environmental impact of the healthcare sector. DORC collaborates actively on projects pushing for circular economy adoption in hospitals through the 10R framework.
• X!LEADminorStrategic or Co-development PartnerX!LEAD is an initiative of Delft University of Technology connecting science graduates with companies to drive innovation. DORC partners with X!LEAD to advance innovation in ophthalmic surgical technology.
• Interreg 2 Seas (3DMed Project)minorStrategic or Co-development PartnerDORC participates in the Interreg 2 Seas 3DMed project focused on the development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Alcon: Global leader in ophthalmic surgical devices including phaco systems (Centurion), vitreoretinal platforms (Constellation), and a full consumables portfolio. Directly competes with DORC across cataract and vitreoretinal OR equipment and consumables.
• Bausch + Lomb (BVI): Major ophthalmic surgical franchise including the Stellaris Elite vitrectomy/cataract platform and broad instrument/consumable lines. Overlaps directly with DORC's EVA NEXUS, vitrectomy cutters, and surgical instrument portfolio.
• Topcon Healthcare: Japanese ophthalmic device maker offering surgical microscopes, OCT, and integrated surgical/visualization systems. Comparable as a diversified ophthalmic equipment vendor serving cataract and vitreoretinal workflows.
• Nidek: Japan-based manufacturer of ophthalmic surgical equipment, phaco and vitrectomy systems, and diagnostic devices. Overlaps directly with DORC in surgical platforms and consumables for cataract and vitreoretinal surgery.

Broad incumbents

• Johnson & Johnson Vision (AMO): Broad incumbent offering ophthalmic surgical equipment, IOLs, and laser cataract surgery platforms. A larger diversified competitor with overlapping OR equipment and consumables but with greater emphasis on IOLs and refractive.
• Carl Zeiss Meditec AG: DORC's parent company and the leading supplier of ophthalmic surgical microscopes, IOLs, and diagnostics. Although now part of the same group, ZEISS's microscope and IOL franchises are the strategic context within which DORC's surgical devices compete globally.

Regional players

• Geuder AG: German manufacturer of ophthalmic surgical instruments, IOLs, and surgical liquids. Comparable to DORC as a European-headquartered peer in ophthalmic surgical devices and consumables with overlapping customer segments.
• Appasamy Associates: India-based manufacturer and distributor of ophthalmic surgical equipment, IOLs, and instruments. Comparable to DORC as a competitor in emerging markets where DORC also distributes via its Indian subsidiary.

Emerging players

• Heidelberg Engineering: Specialized ophthalmic imaging and diagnostics company increasingly active in surgical planning/OR integration. Comparable as a premium ophthalmic device vendor focused on advanced visualization adjacent to DORC's surgical platforms.
• Haag-Streit Surgical (Mannheim): Manufacturer of surgical microscopes and ophthalmic surgical equipment. Comparable to DORC in providing OR-based ophthalmic surgical hardware, though with less emphasis on consumables.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@dorcglobal
• Facebookfacebook.com/DORC-Dutch-Ophthalmic-Research-Center-102690838041999
• LinkedInlinkedin.com/company/dutch-ophthalmic-research-center

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DORC Global